Medical
Cannabis Stock News: Canada House (CSE: $CHV) Announces its Acquisition of
Knalysis Technologies Inc. and Board Changes
TORONTO, ONTARIO - April 10, 2017
(Investorideas.com Newswire) Canada House Wellness Group Inc. ("Canada
House" or the "Company") (CSE:CHV)(CSE:CHV.CN) is pleased to
announce that it has acquired 100% of Knalysis Technologies Inc. "Knalysis"
by way of a stock exchange with 5 million shares of the Company.
Knalysis creates tools for better
cannabis health outcomes by its innovative software that seamlessly links
physicians, providers, and patients, offering a global approach to reporting,
monitoring and care. Its leadership team envisioned a need for health
technology connecting every aspect of the medical marijuana field, and has
pioneered software to meet this need. Its products were developed with a
national network of clinicians in the medical marijuana domain, and are built
to deliver better monitoring of symptoms, moods, and treatments for both
physician and patient.
Knalysis' principals are industry
veterans in technology, data collection, business acumen, and the medical
marijuana vertical. Its team is made up of elites in IT with resumes that
includes substantial work for Microsoft, Boeing, IBM, CERN, McAfee, Bank of
America, and other international organizations.
Knalysis products
include:
- The Knalysis Wellness Tracker
app which empowers users to actively engage in their personal health
monitoring for ailments treated by medical marijuana.
Choose from over 50 ailments, including 100 different moods and symptoms, which can be treated with medical cannabis. Track these in the app, and see habits and patterns emerge to determine which strains are more effective for you. - The Analytics Web Portal
(AWP) which stores and reports on all of the data collected in the
Wellness Tracker app, allowing dispensaries, cultivators, pharmaceutical
companies, and researchers to benefit from complete, comprehensive
reporting on the effectiveness of their strains. The data captured is a
key factor for clients in determining trends in treatment pertaining to
efficacy of phenotypes/strains over time with regards to different
illnesses, and therefore adjusting their prescribing, buying, and
supplying patterns.
- The Cannabis Patient Manager
(CPM) which was developed with a national network of clinicians in the
medical marijuana domain, this web-based tool serves as a secure online
hub of patient health information. With several exclusive features, the
Cannabis Patient Manager is built for more accurate monitoring,
scheduling, and improved patient outcomes. This tool charts medical data
(diagnosis, treatment, dosage, strain preference), allows for online
signatures and self-registration, houses vital information (government
approvals, prescriptions, reports, notes) and manages appointments. The
CPM is built to complement the clinic's natural workflow and mutually
benefits both physician and patient.
In addition, Canada House has elected
two new Directors to its Board, Scott Purdy and Ahmed Rasouli, who together
with the Chairman, form the Board's Audit Committee. They replace David Shpilt
and Edwin Corey whom the company thanks for their services.
Mr. Purdy has built disruptive
businesses in the past, challenging current thinking and producing a completely
new form of business in the healthcare industry which tends to distrust change
of any kind. He is a cannabis professional, holding a MMAR Production License
who has legally grown Cannabis since 2013. He served on the Board of Directors
of Nimble LTD., a product commercialization company, and on the Board of
Directors of Sunnybrook Center for Studies in Aging, Sunnybrook Hospital,
Toronto ON.
Mr. Purdy is a member of the ArcView
Group, Oakland CA and participates in weekly webinars viewing 3 - 5 new
Cannabis-related companies seeking investment capital each week. He worked as a
volunteer for the Red Cross HME Division for two years. During this time, he
developed a new method of equipment recovery to reduce DOS and corresponding
new equipment purchase requirements.
Mr. Rasouli is a seasoned
entrepreneur and business executive. He has created multiple businesses during
his 25-year business career, mainly in the fields of medical and foot-health
clinics and orthotic manufacturing. He founded Abba Medix Corp., now a division
of Canada House, in 2013 to take advantage of the significant changes in
medical marijuana regulations in Canada, raising $2.5 million privately and an
additional $4.3 million when he took the company public.
Canada House
Wellness Group Inc.
Canada House is the parent company of
Marijuana for Trauma, Knalysis Technologies, and Abba Medix Corp. The Company's
goal is to become a marketplace leader through strategic partnerships, mergers,
and acquisitions to create a fully integrated medical cannabis
marketplace.Contact Information
Gerry Goldberg
Interim Chief Executive Officer
Canada House Wellness Group Inc.
1-844-696-3349
Canada House Wellness Group Inc.
1-844-696-3349
Like Marijuana Stocks? View our Marijuana / Hemp
Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp
Stocks - News and Trends in Green Investing
Global
Cannabis Investing -
features Investor Ideas Cannabis news
Get News Alerts on
Marijuana Stocks
Watch the 420 Cannabis Investor video
More Info:
This news is published on the Investorideas.com Newswire - a
global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment